Live
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
- Sales and Marketing: Synchronising Steps for Success
- MATTER begins deliveries of AERA from Ahmedabad, inaugurates first of its kind Experience Hub
- Transforming Education Infrastructure is the key to National Development: Neeraj Sharma, Auxilo Finserve
- Crimson Becomes the First Indian School to Receive WELL Health-Safety Certification for Measures to Boost Physical and Mental Wellbeing
- Trackon Celebrates 20 Years of Innovation and Growth in Logistics
- Hero Motocorp showcases its future mobility vision at Eicma 2024
NPPA revises ceiling price of 883 scheduled formulations
National Pharmaceutical Pricing Authority (NPP) has revised the ceiling price of 883 scheduled formulations.
National Pharmaceutical Pricing Authority (NPP) has revised the ceiling price of 883 scheduled formulations. The Authority in its meeting on Tuesday noted with satisfaction that the supply disruption of active pharmaceutical ingredients (APIs) caused by the coronavirus, COVID-19, outbreak is returning to normalcy.
It said, no unusual price fluctuations in the price of inputs for medicines, amid COVID-19 outbreak has been reported. Hence, normal price revisions have been allowed.
The Ministry of Chemicals and Fertilizers in its release said, "In compliance of the provisions of Drugs (Price Control) Order 2013, NPPA has revised/ increased the ceiling price of 883 scheduled formulations."
The WPI increase has been based on the data published by the Department for Promotion of Industry and Internal Trade, Union Ministry of Commerce and Industry. Increase in ceiling price is based on the Wholesale Price Index (WPI) which is 1.88468 per cent.
The revision in the ceiling price of formulations includes the revision of the ceiling price of cardiac stents also. The revised prices will be applicable from today, April 11, 2020.
